General Practice
Processes biological signals (DNA/Blood) for screening across many adverse conditions along with preventive guidance and pattern detection.
Analytics, Interpretation, and Reporting Infrastructure for Laboratories
FlahyCDS identifies clinically actionable testing opportunities, supports appropriate test utilization, and converts biological signals into clinician-ready reports with guidance on next steps.
Covers treatment implications across General Practice, Cardiology, Neurology, Psychiatry, and more.
Areas of Use
One platform across general practice and specialities. Choose a pre-defined workflow, or a custom workflow built for your markers of choice
Internal Medicine, Cardiology, & Pediatrics
Markers linked to diagnosis and treatment personalization. Pharmacogenomic analysis for medication and dosage fitness.
Oncology
Sensitivity and resistance markers with treatment implications. MSI, TMB, and HRD scores with implications for relevant therapies.
Neurology & Psychiatry
Markers associated with diagnosis of neurological conditions. HLA typing for immunological interactions with anticonvulsants.
How FlahyCDS Works
Ingest
Takes the available biological signals alongside the clinical context accompanying the sample — one picture per patient.
Interpret
Analyses the data to detect markers with clinical implications given the clinical context, and what the next steps should be in-line with guideline logic.
Report
Produces a clinician-ready report that states the clinical implications of each finding and suggests relevant additional testing for better care when applicable.
End-to-End Decision Infrastructure for Advanced Diagnostics
FlahyCDS provides the secure workflow layer that enterprises and laboratories need to deploy clinical decision support and advanced diagnostics at scale.
From identifying the right clinical windows for advanced testing to interpreting diagnostic data and generating clinician-ready reports, FlahyCDS brings the core components of diagnostic decision support into one scalable platform.
Built for privacy-sensitive, high-volume environments, FlahyCDS helps organizations bring advanced diagnostics into clinical and laboratory workflows without building the full decision support, interpretation, and reporting infrastructure from scratch.
Identify
Interpret
Report
For Laboratories - Novel Immuno-Oncology
Via FlahyCDS, diagnostic laboratories can also provide prognostic insights to their oncology patients using FlahyRecovery™, Flahy’s novel biomarker. Learn more here (↗)
Deploy FlahyCDS
Request a demo to explore how FlahyCDS can support your health system, laboratory, or advanced diagnostics program.
Flahy
Care As Unique As You™